StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) operating KPIs

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)

Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%

Johnson & Johnson other Oncology medicines — Worldwide reported growth YoY (%) (%)

Form 8-K EX-99.2 Segment Sales Schedule

QuarterlyAnnual
Latest, Q3 2026
26.3%
Period ended Sep 30, 2026
Change on a year earlier
+16.6 pts
9.7% in Q3 2025
History
32 quarters
Since Q4 2017
Sources
32
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Oncology medicines — Worldwide reported growth YoY (%) (%)Year on yearSource
Q3 2026Sep 30, 202626.3%+16.6 ptsForm 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗
Q2 2026Jun 28, 2026-4.6%-16.3 ptsForm 8-K (a2026q2exhibit991.htm, filed 2026-07-15) ↗
Q1 2026Mar 29, 2026-10.6%-32.3 ptsForm 8-K (a2026q1exhibit991.htm, filed 2026-04-14) ↗
Q4 2025Dec 28, 202532.9%-57.5 ptsForm 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Q3 2025Sep 28, 20259.7%–Form 8-K (a2025q3exhibit991.htm, filed 2025-10-14) ↗
Q2 2025Jun 29, 202511.7%-72.5 ptsForm 8-K (a2025q2exhibit991.htm, filed 2025-07-16) ↗
Q1 2025Mar 30, 202521.7%-58.5 ptsForm 8-K (a2025q1exhibit991.htm, filed 2025-04-15) ↗
Q4 2024Dec 29, 202490.4%–Form 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗
Q2 2024Jun 30, 202484.2%–Form 8-K (a2024q2exhibit991.htm, filed 2024-07-17) ↗
Q1 2024Mar 31, 202480.2%+42.8 ptsForm 8-K (a2024q1exhibit991.htm, filed 2024-04-16) ↗
Q1 2023Apr 2, 202337.4%+72.5 ptsForm 8-K (a2023q1exhibit991.htm, filed 2023-04-18) ↗
Q4 2022Jan 1, 202320.6%+51.9 ptsForm 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗
Q3 2022Oct 2, 202223.1%+60.7 ptsForm 8-K (a2022q3exhibit991.htm, filed 2022-10-18) ↗
Q2 2022Jul 3, 20227.5%+48.4 ptsForm 8-K (a2022q2exhibit991.htm, filed 2022-07-19) ↗
Q1 2022Apr 3, 2022-35.1%-20.9 ptsForm 8-K (a2022q1exhibit991.htm, filed 2022-04-19) ↗
Q4 2021Jan 2, 2022-31.3%-33.0 ptsForm 8-K (a2021q4exhibit991.htm, filed 2022-01-25) ↗

Cite this data

StockData. (2026). Johnson & Johnson Other Oncology medicines — Worldwide reported growth YoY (%) (%), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/drug_other_onc_rep_yoy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.